References
Arno AG, Farré M, Rodríguez-Morató J, et al. Pharmacokinetics in morbid obesity: influence of two bariatric surgery techniques on paracetamol and caffeine metabolism. Obes Surg. Springer US. 40(6):1–8.
Dobrinas M, Cornuz J, Oneda B, et al. Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility. Clin Pharmacol Ther. 2011;90(1):117–25.
Faber MS, Fuhr U. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther. 2004;76(2):178–84.
Faber MS, Jetter A, Fuhr U. Assessment of CYP1A2 activity in clinical practice: why, how, and when? Basic Clin Pharmacol Toxicol. 2005;97(3):125–34.
Vistisen K, Poulsen HE, Loft S. Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis. 1992;13(9):1561–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Grant Support
No grant support was received.
Conflict of Interest
ᅟ
The authors declare that they have no conflict of interest.
ᅟ
Rights and permissions
About this article
Cite this article
Ferreira, V., Wang, J.J., Villeneuve, E. et al. Letter in Reply to Arno et al. “Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism”. OBES SURG 27, 3004–3005 (2017). https://doi.org/10.1007/s11695-017-2895-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-017-2895-z